China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Ceftazidime/Avibactam for Multi-drug Resistant Infections in ICU'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136533
Registration Time: 2026/11/11
Type: Observational study
Primary Sponsor: Renmin Hospital of Wuhan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351970
Published by HT Digital Content Services with permission from Health Daily Digest....